Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores

Journal of Medical Microbiology

Volumn 64, Issue 1, 2015, Pages 104-110

  Zhou, Zhenwen ^a   Gong, Sitang ^a   Yang, Yiyu ^a   Guan, Ruili ^a   Zhou, Shuai ^a   Yao, Shuwen ^a   Xie, Yongqiang ^a   Ou, Zhiying ^a   Zhao, Junhong ^a   Li, Xiu Min ^b   Liu, Zhigang ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Shenzhen University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; GENOMIC DNA; HELICOBACTER PYLORI VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; UREASE; UREASE B; BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SECRETORY IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL LOAD; BACTERIAL SPORE; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMORAL IMMUNITY; IMMUNIZATION; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTECTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL SURFACE DISPLAY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; STOMACH;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACILLUS SUBTILIS; BACTERIAL LOAD; BACTERIAL VACCINES; CELL SURFACE DISPLAY TECHNIQUES; GENE EXPRESSION; HELICOBACTER PYLORI; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MALE; MEMBRANE PROTEINS; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SPORES, BACTERIAL; STOMACH; UREASE; VACCINES, SYNTHETIC;

EID: 84919705414     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.076430-0     Document Type: Article

References (42)

1. Akhiani, A. A., Schön, K., Franzén, L. E., Pappo, J. & Lycke, N. (2004). Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol 172, 5024-5033.
2. Bégué, R. E. & Sadowska-Krowicka, H. (2010). Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model. FEMS Immunol Med Microbiol 60, 142-146.
3. Bhuiyan, T. R., Saha, A., Lundgren, A., Qadri, F. & Svennerholm, A. M. (2010). Immune responses to Helicobacter pylori infection in Bangladeshi children during their first two years of life and the association between maternal antibodies and onset of infection. J Infect Dis 202, 1676-1684.
4. Brandtzaeg, P. (2010). Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest 39, 303-355.
5. Czinn, S. J. & Blanchard, T. (2011). Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 8, 133-140.
6. de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D. & Plummer, M. (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13, 607-615.
7. DeLyria, E. S., Redline, R. W. & Blanchard, T. G. (2009). Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136, 247-256.
8. Driks, A. (1999). Bacillus subtilis spore coat. Microbiol Mol Biol Rev 63, 1-20.
9. Duc, H., Hong, H. A., Fairweather, N., Ricca, E. & Cutting, S. M. (2003). Bacterial spores as vaccine vehicles. Infect Immun 71, 2810-2818.
10. Duc, H., Hong, H. A., Atkins, H. S., Flick-Smith, H. C., Durrani, Z., Rijpkema, S., Titball, R. W. & Cutting, S. M. (2007). Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen. Vaccine 25, 346-355.
11. Eaton, K. A., Brooks, C. L., Morgan, D. R. & Krakowka, S. (1991). Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 59, 2470-2475.
12. Ermak, T. H., Giannasca, P. J., Nichols, R., Myers, G. A., Nedrud, J., Weltzin, R., Lee, C. K., Kleanthous, H. & Monath, T. P. (1998). Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188, 2277-2288.
13. Handa, O., Naito, Y. J. & Yoshikawa, T. (2011). Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Rep 16, 1-7.
14. Hatzifoti, C., Roussel, Y., Harris, A. G., Wren, B. W., Morrow, J. W. & Bajaj-Elliott, M. (2006). Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Helicobacter 11, 113-122.
15. He, B., Xu, W., Santini, P. A., Polydorides, A. D., Chiu, A., Estrella, J., Shan, M., Chadburn, A., Villanacci, V. & other authors (2007). Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826.
16. Kleanthous, H., Myers, G. A., Georgakopoulos, K. M., Tibbitts, T. J., Ingrassia, J. W., Gray, H. L., Ding, R., Zhang, Z. Z., Lei, W. & other authors (1998). Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 66, 2879-2886.
17. Kritas, S. K., Govaris, A., Christodoulopoulos, G. & Burriel, A. R. (2006). Effect of Bacillus licheniformis and Bacillus subtilis supplementation of ewe’s feed on sheep milk production and young lamb mortality. J Vet Med A Physiol Pathol Clin Med 53, 170-173.
18. Lamprecht, M., Bogner, S., Schippinger, G., Steinbauer, K., Fankhauser, F., Hallstroem, S., Schuetz, B. & Greilberger, J. F. (2012). Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr 9, 45.
19. Lee, J. S., Cho, J. Y., Song, H., Kim, E. H. & Hahm, K. B. (2012). Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling. J Clin Biochem Nutr 51, 77-83.
20. Lee, J. W., Kim, N., Kim, J. M., Nam, R. H., Chang, H., Kim, J. Y., Shin, C. M., Park, Y. S., Lee, D. H. & Jung, H. C. (2013). Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 18, 206-214.
21. Leighton, T. J. & Doi, R. H. (1971). The stability of messenger ribonucleic acid during sporulation in Bacillus subtilis. J Biol Chem 246, 3189-3195.
22. Li, Y., Ning, Y., Wang, Y., Peng, D., Jiang, Y., Zhang, L., Long, M., Luo, J. & Li, M. (2010). Mimotopes selected with a neutralizing antibody against urease B from Helicobacter pylori induce enzyme inhibitory antibodies in mice upon vaccination. BMC Biotechnol 10, 84.
23. Liu, K. Y., Shi, Y., Luo, P., Yu, S., Chen, L., Zhao, Z., Mao, X. H., Guo, G., Wu, C. & Zou, Q. M. (2011). Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine 29, 6679-6685.
24. Mauriello, E. M., Duc, H., Isticato, R., Cangiano, G., Hong, H. A., De Felice, M., Ricca, E. & Cutting, S. M. (2004). Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner. Vaccine 22, 1177-1187.
25. Nakamura, S., Sugiyama, T., Matsumoto, T., Iijima, K., Ono, S., Tajika, M., Tari, A., Kitadai, Y., Matsumoto, H. & other authors (2012). Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61, 507-513.
26. Negri, A., Potocki, W., Iwanicki, A., Obuchowski, M. & Hinc, K. (2013). Expression and display of Clostridium difficile protein FliD on the surface of Bacillus subtilis spores. J Med Microbiol 62, 1379-1385.
27. Nicholson, W. L. & Setlow, P. (1990). Sporulation, germination and outgrowth. In Molecular Biological Methods for Bacillus, pp. 391-450. Edited by C. R. Harwood & S. M. Cutting. Chichester: Wiley.
28. Nicholson, W. L., Munakata, N., Horneck, G., Melosh, H. J. & Setlow, P. (2000). Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev 64, 548-572.
29. Raghavan, S., Ostberg, A. K., Flach, C. F., Ekman, A., Blomquist, M., Czerkinsky, C. & Holmgren, J. (2010). Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun 78, 4251-4260.
30. Robinson, K., Chamberlain, L. M., Schofield, K. M., Wells, J. M. & Le Page, R. W. F. (1997). Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15, 653-657.
31. Spizizen, J. (1958). Transformation of biochemically deficient strains of Bacillus subtilis by deoxyribonucleotide. Proc Natl Acad Sci U S A 44, 1072-1078.
32. Su, P., Li, Y., Li, H., Zhang, J., Lin, L., Wang, Q., Guo, F., Ji, Z., Mao, J. & other authors (2013). Antibiotic resistance of Helicobacter pylori isolated in the southeast coastal region of China. Helicobacter 18, 274-279.
33. Summerton, N. A., Welch, R. W., Bondoc, L., Yang, H. H., Pleune, B., Ramachandran, N., Harris, A. M., Bland, D., Jackson, W. J. & other authors (2010). Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin. Vaccine 28, 1404-1411.
34. Toller, I. M., Neelsen, K. J., Steger, M., Hartung, M. L., Hottiger, M. O., Stucki, M., Kalali, B., Gerhard, M., Sartori, A. A. & other authors (2011). Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A 108, 14944-14949.
35. Tsuda, M., Karita, M., Morshed, M. G., Okita, K. & Nakazawa, T. (1994). A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect Immun 62, 3586-3589.
36. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. & Schlemper, R. J. (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345, 784-789.
37. Vermoote, M., Van Steendam, K., Flahou, B., Smet, A., Pasmans, F., Glibert, P., Ducatelle, R., Deforce, D. & Haesebrouck, F. (2012). Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model. Vet Res 43, 72.
38. You, Y., Liu, L., Zhang, M., Han, X., He, L., Zhu, Y., Ni, P. & Zhang, J. (2012). Genome sequences of three Helicobacter pylori strains isolated from atrophic gastritis and gastric ulcer patients in China. J Bacteriol 194, 6314-6315.
39. Zhang, X. Z., Cui, Z. L., Hong, Q. & Li, S. P. (2005). High-level expression and secretion of methyl parathion hydrolase in Bacillus subtilis WB800. Appl Environ Microbiol 71, 4101-4103.
40. Zhao, W., Wu, W. & Xu, X. (2007). Oral vaccination with liposomeencapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Vaccine 25, 7664-7673.
41. Zhou, Z. W., Xia, H. M., Hu, X., Huang, Y., Li, Y., Li, L., Ma, C. L., Chen, X. X., Hu, F. Y. & other authors (2008a). Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis. Vaccine 26, 1817-1825.
42. Zhou, Z. W., Xia, H. M., Hu, X. C., Huang, Y., Ma, C. L., Chen, X. X., Hu, F. Y., Xu, J., Lu, F. L. & other authors (2008b). Immunogenicity of recombinant Bacillus subtilis spores expressing Clonorchis sinensis tegumental protein. Parasitol Res 102, 293-297.